MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Myomo DPO Ratio 2011-2026 | MYO
Annual DPO Ratio Myomo
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.5 | 46.5 | 25.3 | 179 | 214 | 191 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 214 | 25.3 | 117 |
Quarterly DPO Ratio Myomo
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.8 | 63.4 | 51.8 | - | 53.9 | 45.7 | 59.6 | - | 56.9 | 45.5 | 59.1 | - | 30.1 | 36.3 | 61.4 | - | 50.8 | 67.1 | 65.5 | - | 19.3 | 39.3 | 90.3 | - | 125 | 108 | 139 | - | 201 | 194 | 292 | - | 195 | 245 | 334 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 334 | 19.3 | 103 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 12.42 | -4.46 % | $ 1.86 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
48.8 | - | 1.37 % | $ 20.5 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 38.55 | 0.13 % | $ 5.74 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
81.1 | $ 8.31 | 1.4 % | $ 597 M |  Israel |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 9.61 | -0.62 % | $ 1.3 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
47.8 | $ 24.26 | -0.12 % | $ 205 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 41.66 | -3.09 % | $ 1.29 B | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 4.19 | -1.41 % | $ 156 M |  France |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
34.4 | $ 29.15 | -0.24 % | $ 1.34 B | USA |
 |
Apyx Medical Corporation
APYX
|
52.8 | $ 3.27 | -0.82 % | $ 113 M | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | Israel |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.59 | 0.3 % | $ 122 M | USA |
 |
Accuray Incorporated
ARAY
|
49.2 | $ 0.5 | -4.78 % | $ 51.4 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
125 | $ 0.81 | 1.91 % | $ 44.1 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 175.78 | -3.51 % | $ 13.2 B | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 3.7 | -8.31 % | $ 783 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
79.7 | $ 110.91 | -1.94 % | $ 193 B | USA |
 |
InMode Ltd.
INMD
|
72.7 | $ 13.49 | -0.55 % | $ 872 M | Israel |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 72.61 | 0.55 % | $ 107 B | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 1.4 | -0.71 % | $ 22.6 M | USA |
 |
IRadimed Corporation
IRMD
|
40.6 | $ 100.27 | -4.6 % | $ 1.27 B | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.26 | -2.16 % | $ 1.37 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 17.55 | -5.03 % | $ 412 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 83.7 | -1.78 % | $ 48.9 B | USA |
 |
Pulmonx Corporation
LUNG
|
44.6 | $ 1.61 | 12.07 % | $ 63 M | USA |
 |
Inogen
INGN
|
34.6 | $ 6.53 | 3.41 % | $ 174 M | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 64.29 | -1.49 % | $ 3.51 B |  Britain |